International collaboration on advanced manufacturing
Highly accurate non-invasive nuclear technique helps validate theoretical model for optimised laser material deposition in additive manufacturing.
Showing 61 - 80 of 201 results
Australia amongst the world's best in the international nuclear arena
On the international stage amongst the leading nuclear nations of the world, Australians hold its own. This status has been earned by ANSTO’s seventy-year history of safe nuclear operations, the application of nuclear science and technology to benefit society and nuclear stewardship role in Australia.
Non-invasive skin cancer treatment manufactured by ANSTO in Southern Sydney
ANSTO has been licensed as the Australian manufacturing partner of an innovative, non-invasive treatment for non-melanoma skin cancer (NMSC).
Acute Myeloid Leukemia
New therapy targets aggressive form of leukaemia
ANSTO strengthens its collaboration with IAEA to support environmental protection
Stronger research link with IAEA with the establishment of Collaborating Centre at ANSTO to support environment and cultural heritage activities
ANSTO scientists help refine estimates of global methane emissions
A groundbreaking international study has provided new insights into global fossil methane emissions, using innovative multi-isotopic atmospheric measurements.
ANSTO Hosted IAEA Pacific Islands Workshop in February 2024
In early February, ANSTO was honoured to host the International Atomic Energy Agency (IAEA) National Liaison Officers Meeting and Sub Regional Approach to the Pacific Islands (SAPI) Programme, which focused on the development and delivery of the IAEA Technical Cooperation Programme in the Pacific.
Seeing clearly: Young researcher honoured for pushing microscope boundaries
Senior Scientist - X-ray Fluorescence Microscopy
Role at ANSTO
Combining irradiation and lithography to engineer advanced conducting materials
Synchrotron-studied protein sheds light on Parkinson’s, stomach cancer, melanoma
Collaboration across the Tasman has enabled Australian and New Zealand researchers and scientists to shed light on a protein involved in diseases such as Parkinson’s disease, gastric cancer and melanoma.
Carbon nanotubes exhibit outstanding electrochemical reduction of CO2
New class of single atoms catalysts for carbon nanotubes characterised.
Deciphering the complex molecular activity that leads to cell death
Research on the mechanism of cell death has insights to bring progress on neurodegenerative diseases and plant biosecurity.
A step closer to understanding superconductivity with large international collaboration
Highlights - Aerosol Sampling
ANSTO has been tracking and publishing data on fine particle pollution from key sites around Australia, and internationally, for more than 20 years.
Distinguished lecture: Understanding depression
Aussie scientists to develop $500 million-dollar project in Mexico
Two Australian scientists have been appointed to assist with the development of a $500 million-dollar synchrotron facility in Mexico, the first and largest project of its kind.
ANSTO shining a light on the Australian Synchrotron's $100M BRIGHT beamlines
A special inaugural event held by ANSTO at its Australian Synchrotron for more than 30 funding organisations has showcased the first of the $100 million BRIGHT Program’s brand new, state-of-the-art beamlines.
Major study identifies a potential drug target for lowering cholesterol
Study explored how key proteins manage dietary cholesterol absorption and elucidated crucial transport mechanisms that contribute to cholesterol balance in the body.